PillPlerixafor
Brands: Mozobil · Plerixafor
8 active makers
soon
soon
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it8 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 1 | SUPPLYING |
| Novadoz Pharmaceuticals LLC | unknown | 1 | SUPPLYING |
| Fresenius Kabi USA, LLC | unknown | 1 | SUPPLYING |
| Sanofi-Aventis U.S. LLC | unknown | 1 | SUPPLYING |
| Sagent Pharmaceuticals | unknown | 1 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
| Amneal Pharmaceuticals LLC | unknown | 1 | SUPPLYING |
| Gland Pharma Limited | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Mar 13, 2026RESOLVEDShortage resolved: Plerixafor Injection (Fresenius Kabi USA, LLC)
Plerixafor Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Hematology.
- Mar 13, 2026SHORTAGEDrug shortage: Plerixafor Injection (Fresenius Kabi USA, LLC)
Plerixafor Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Hematology.
- Sep 1, 2016RECALLRecall (Class III): Mozobil (plerixafor injection) 24mg/1.2mL (20mg/mL), For Single Use Only, Rx Only, Manufactured by: Genzyme Corporation…
Labeling: Incorrect or Missing Package Insert — Recalling firm: Sanofi-Aventis U.S. LLC — Nattionwide
- Aug 4, 2016RECALLRecall (Class III): Mozobil (plerixafor injection) 24 mg/1.2 mL (20 mg/mL) per vial, Rx Only, For Subcutaneous Injection only, Manufactured…
Labeling: Incorrect or Missing Lot and/or Exp. Date — Recalling firm: Genzyme Corporation / Genzyme Biosurgery — nationwide